South Dakota Senate vote

The “Classify medetomidine as a Schedule III controlled substance and establish permissible uses” (HB 1169)

Official title: Classify medetomidine as a Schedule III controlled substance and establish permissible uses.

Passed: 32 yes, 0 no, 3 not voting

Feb 26, 2026 · , HB 1169